Pfizer vaccine: "Yes" from the FDA to children 6 months to 4 years old
The Committee of Experts of the American Drug Administration has unanimously advocated for the administration of the Pfizer vaccine to children from 6 months to 4 years of age.
FILE PHOTO: A vial labeled "Pfizer COVID-19 Vaccine "is seen in this illustration taken January 16, 2022. REUTERS / Dado Ruvic / Illustration
His advisory committee of experts American Drug Administration (FDA) today gave its opinion in favor of Pfizer vaccine against it Covid-19 to children between 6 months and 4 years, the last age group that can not yet be vaccinated against the new coronavirus in the US, as in many other countries.
This unanimous recommendation from the 21 members of the committee comes immediately after a similar opinion was given on Moderna vaccine, for infants and young children.
The FDA is now expected to make its decision to approve these two vaccines for infants, a decision that rarely differs from that of the committee.